Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 2.17% is 49% above its 5-year average of 1.46%, around the middle of its 5-year range (-26.87%–29.40%).
134.69% above its 12-month average of -6.26%.
Annual fiscal-year return on assets; no daily interpolation. Historical series through 2025-12-31.
RETURN ON ASSETS (ROA)
2.17%
RETURN ON ASSETS (ROA) AVG TTM
-6.26%
RETURN ON ASSETS (ROA) AVG 3Y
-11.14%
RETURN ON ASSETS (ROA) AVG 5Y
1.46%
RETURN ON ASSETS (ROA) AVG 10Y
3.96%
RETURN ON ASSETS (ROA) AVG 15Y
4.18%
RETURN ON ASSETS (ROA) AVG 20Y
4.58%
CURRENT VS TTM AVG
+134.69%
CURRENT VS 3Y AVG
+119.48%
CURRENT VS 5Y AVG
+48.97%
CURRENT VS 10Y AVG
-45.25%
CURRENT VS 15Y AVG
-48.05%
CURRENT VS 20Y AVG
-52.67%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-57.78%
vs the sector median at left
Bio-Rad Laboratories, Inc.
Market Cap
$9.93B
Return on Assets (ROA)
2.17%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
Market Cap
$9.92B
Return on Assets (ROA)
9.76%
TTM Avg
6.05%
3Y Avg
5.92%
5Y Avg
6.23%
Market Cap
$9.94B
Return on Assets (ROA)
3.54%
TTM Avg
3.68%
3Y Avg
4.39%
5Y Avg
5.01%
Market Cap
$10.07B
Return on Assets (ROA)
6.59%
TTM Avg
6.34%
3Y Avg
6.05%
5Y Avg
6.29%
Market Cap
$10.29B
Return on Assets (ROA)
-10.75%
TTM Avg
-43.49%
3Y Avg
-42.71%
5Y Avg
-41.26%
Market Cap
$10.45B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$10.46B
Return on Assets (ROA)
9.58%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
Market Cap
$9.33B
Return on Assets (ROA)
11.86%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$10.56B
Return on Assets (ROA)
4.50%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | $9.93B | 2.17% | -6.26% | -11.14% | 1.46% |
| Globus Medical, Inc. (GMED)vs › | $9.92B | 9.76% | 6.05% | 5.92% | 6.23% |
| Henry Schein, Inc. (HSIC)vs › | $9.94B | 3.54% | 3.68% | 4.39% | 5.01% |
| The Ensign Group, Inc. (ENSG)vs › | $10.07B | 6.59% | 6.34% | 6.05% | 6.29% |
| Tempus AI, Inc. (TEM)vs › | $10.29B | -10.75% | -43.49% | -42.71% | -41.26% |
| Molina Healthcare, Inc. (MOH)vs › | $10.45B | -0.04% | 5.29% | 6.08% | 6.13% |
| Universal Health Services, Inc. (UHS)vs › | $10.46B | 9.58% | 8.61% | 6.84% | 6.99% |
| Insulet Corp. (PODD)vs › | $9.33B | 11.86% | 10.65% | 7.37% | 5.11% |
| The Cooper Companies, Inc. (COO)vs › | $10.56B | 4.50% | 3.10% | 3.02% | 7.71% |
| Align Technology, Inc. (ALGN)vs › | $10.79B | 6.44% | 6.68% | 6.69% | 12.75% |
ROA
2.2%
ROE
3.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 7.18% |
| 2024-12-31 | -19.69% |
| 2023-12-31 | -5.18% |
| 2022-12-31 | -26.87% |
| 2021-12-31 | 23.90% |
| 2020-12-31 | 29.40% |
| 2019-12-31 | 21.96% |
| 2018-12-31 | 6.43% |
| 2017-12-31 | 2.69% |
| 2016-12-31 | 0.73% |
| 2015-12-31 | 3.05% |
| 2014-12-31 | 2.66% |
| 2013-12-31 | 2.30% |
| 2012-12-31 | 4.91% |
| 2011-12-31 | 5.76% |
| 2010-12-31 | 6.06% |
| 2009-12-31 | 5.70% |
| 2008-12-31 | 4.39% |
| 2007-12-31 | 4.72% |
| 2006-12-31 | 6.47% |
| 2005-12-31 | 5.72% |
| 2004-12-31 | 4.98% |
| 2003-12-31 | 7.67% |
| 2002-12-31 | 9.42% |
| 2001-12-31 | 6.46% |
| 2000-12-31 | 4.81% |
| 1999-12-31 | 1.75% |
| 1998-12-31 | 6.62% |
| 1997-12-31 | 4.66% |
| 1996-12-31 | 9.20% |
